1-10 of 10
Therapeutics & Molecular Medicine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Modeling Parkinson’s disease in LRRK2 rodents

Open Access
Chiara Domenicale, Stefano Magnabosco, Michele Morari
Journal: Neuronal Signaling
Neuronal Signal (2023) 7 (3): NS20220040.
https://doi.org/10.1042/NS20220040
Published: 16 August 2023
View articletitled, Modeling Parkinson’s disease in LRRK2 rodents
Open the PDF for Modeling Parkinson’s disease in LRRK2 rodents in another window
Articles

Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders

Open Access
Arthur A. Coelho, Sávio Lima-Bastos, Pedro H. Gobira, Sabrina F. Lisboa
Journal: Neuronal Signaling
Neuronal Signal (2023) 7 (2): NS20220034.
https://doi.org/10.1042/NS20220034
Published: 25 July 2023
View articletitled, Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders
Open the PDF for Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders in another window
Articles

Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin

Open Access
Myles Corrigan, Aoife M. O'Rourke, Barry Moran, Jean M. Fletcher, Andrew Harkin
Journal: Neuronal Signaling
Neuronal Signal (2023) 7 (2): NS20220054.
https://doi.org/10.1042/NS20220054
Published: 13 July 2023
View articletitled, Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Open the PDF for Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin in another window
Articles

The role of thalamic group II mGlu receptors in health and disease

Open Access
In Collection
Celebrating 125 years of the Synapse
Caroline S. Copeland, Thomas E. Salt
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (4): NS20210058.
https://doi.org/10.1042/NS20210058
Published: 15 November 2022
View articletitled, The role of thalamic group II mGlu receptors in health and disease
Open the PDF for The role of thalamic group II mGlu receptors in health and disease in another window
Articles

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease

Open Access
Louis Dwomoh, Gonzalo S. Tejeda, Andrew B. Tobin
Journal: Neuronal Signaling
Neuronal Signal (2022) 6 (1): NS20210004.
https://doi.org/10.1042/NS20210004
Published: 21 April 2022
View articletitled, Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Open the PDF for Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease in another window
Articles

Cannabidiol modulation of oxidative stress and signalling

Open Access
Sónia R. Pereira, Becky Hackett, David N. O’Driscoll, Melody Cui Sun, Eric J. Downer
Journal: Neuronal Signaling
Neuronal Signal (2021) 5 (3): NS20200080.
https://doi.org/10.1042/NS20200080
Published: 24 August 2021
View articletitled, Cannabidiol modulation of oxidative stress and signalling
Open the PDF for Cannabidiol modulation of oxidative stress and signalling in another window
Articles

5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression

Open Access
Minal Jaggar, Toshali Banerjee, Noelia Weisstaub, Jay A. Gingrich, Vidita A. Vaidya
Journal: Neuronal Signaling
Neuronal Signal (2019) 3 (1): NS20180205.
https://doi.org/10.1042/NS20180205
Published: 01 February 2019
View articletitled, 5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression
Open the PDF for 5-HT 2A receptor loss does not alter acute fluoxetine-induced anxiety and exhibit sex-dependent regulation of cortical immediate early gene expression in another window
Includes: Supplementary data
Articles

Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

Open Access
J. Daniel Lafreniere, Melanie E.M. Kelly
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (4): NS20170144.
https://doi.org/10.1042/NS20170144
Published: 02 November 2018
View articletitled, Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
Open the PDF for Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options in another window
Articles

Therapeutic use of botulinum toxin in pain treatment

Open Access
Raj Kumar
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (3): NS20180058.
https://doi.org/10.1042/NS20180058
Published: 31 August 2018
View articletitled, Therapeutic use of botulinum toxin in pain treatment
Open the PDF for Therapeutic use of botulinum toxin in pain treatment in another window
Articles

Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?

Open Access
Sarah J. Bailey, Stephen M. Husbands
Journal: Neuronal Signaling
Neuronal Signal (2018) 2 (2): NS20170145.
https://doi.org/10.1042/NS20170145
Published: 14 May 2018
View articletitled, Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists?
Open the PDF for Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists? in another window